Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
about
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Durvalumab and Tremelimumab ± ...... Squamous or Non-Squamous NSCLC
@en
Durvalumab and Tremelimumab ± ...... Squamous or Non-Squamous NSCLC
@nl
type
label
Durvalumab and Tremelimumab ± ...... Squamous or Non-Squamous NSCLC
@en
Durvalumab and Tremelimumab ± ...... Squamous or Non-Squamous NSCLC
@nl
prefLabel
Durvalumab and Tremelimumab ± ...... Squamous or Non-Squamous NSCLC
@en
Durvalumab and Tremelimumab ± ...... Squamous or Non-Squamous NSCLC
@nl
P6153
P1050
P3098
NCT03057106